SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001759425-24-000031
Filing Date
2024-08-07
Accepted
2024-08-07 16:11:27
Documents
82
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-20240630.htm   iXBRL 10-Q 1666729
2 EX-10.1 mirm-10qq224xexx101.htm EX-10.1 23169
3 EX-31.1 mirm-10qq224xexx311.htm EX-31.1 10573
4 EX-31.2 mirm-10qq224xexx312.htm EX-31.2 11462
5 EX-32.1 mirm-10qq224xexx321.htm EX-32.1 5145
6 EX-32.2 mirm-10qq224xexx322.htm EX-32.2 5861
  Complete submission text file 0001759425-24-000031.txt   8111583

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20240630.xsd EX-101.SCH 61090
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mirm-20240630_cal.xml EX-101.CAL 77105
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mirm-20240630_def.xml EX-101.DEF 280468
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20240630_lab.xml EX-101.LAB 717675
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20240630_pre.xml EX-101.PRE 501277
85 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20240630_htm.xml XML 1033797
Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 241183863
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)